Lactobacillus salivarius UALs07 and Improved Gut Microbiota

• Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults.

  • 2010-06
  • RCT · n = 40
  • Anaerobe 16(3)
  • • S. Sierra
    • F. Lara‐Villoslada
    • Lluis Sempere
    • M. Olivares
    • J. Boza
    • J. Xaus

  • PubMed: 20159049
  • DOI: 10.1016/j.anaerobe.2010.02.001

  7 Insights on

  • Improved Gut Microbiota

  • High evidence
  • Highly Cited

  Consumption of the probiotic strain increased fecal lactobacilli counts (7.9+/-0.1 vs. 7.05+/-0.2 CFU/g feces, P=0.001).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes

• The synergy of dietary supplements Lactobacillus salivarius LI01 and Bifidobacterium longum TC01 in alleviating liver failure in rats treated with D-galactosamine.

  • 2022-01-31
  • Clinical Trial
  • Food & Function 12(20)
  • • Aoxiang Zhuge
    • Shengjie Li
    • Yin Yuan
    • Bo Li
    • Lanjuan Li

  • PubMed: 34546256
  • DOI: 10.1039/d1fo01807h

  4 Insights on

  • Improved Gut Microbiota

  • Low evidence
  • Animal Study

  Supplementation with LI01 and TC01 markedly alleviates gut dysbiosis in the G-DaIN-treated rats, with enrichment of short chain fatty acid (SCFA) producers Faecalibaculum and _Eubacterium_xylanophilum__group, a decreased Firmicutes/Bacteroidetes (F/B) ratio and depletion of proinflammatory microbes, such as Peptococcaeae and Ruminococcaceae_UCG-005.

  Effect

  Beneficial

  Effect size

  Moderate